The Food and Drug Administration on Monday amended the emergency use authorization for the Pfizer-BioNTech coronavirus vaccine to expand eligibility for booster doses to individuals ages 12 to 15.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
